ACAD
40.55
+0.33
+0.82%
AEMD
8.75
-0.1
-1.13%
APRI
1.56
+0.06
+4.00%
ARNA
4.19
-0.01
-0.24%
ATEC
1.36
+0.01
+0.74%
CNAT
5.36
+0.04
+0.75%
CRXM
0.5
0.00
0.00%
CYTX
0.66
-0.021
-3.0548%
DXCM
68.68
+0.43
+0.63%
GNMK
9.04
+0.01
+0.11%
HALO
17.45
+0.2
+1.16%
ILMN
205
+1.88
+0.93%
INNV
0.153
+0.003
+1.6667%
INO
8.83
+0.57
+6.90%
ISCO
0.05
0.00
0.00%
ISIS
67.76
+0.59
+0.88%
LGND
89.67
+0.44
+0.49%
LPTN
0.305
+0.008
+2.6599%
MBVX
2.29
-0.09
-3.78%
MEIP
1.87
-0.04
-2.09%
MNOV
4.05
+0.05
+1.25%
MRTX
26.81
+0.97
+3.75%
MSTX
0.49
-0.01
-2.97%
NBIX
42.55
+0.57
+1.36%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.65
-0.03
-0.64%
OREX
5.01
+0.01
+0.20%
OTIC
24.86
-6.19
-19.94%
QDEL
21.84
-0.89
-3.92%
RCPT
161.65
+1.54
+0.96%
RGLS
12.85
+0.1
+0.78%
RMD
57.08
-0.24
-0.42%
SCIE
0.02
+0.005
+30.2632%
SPHS
0.845
-0.014
-1.630%
SRNE
12.94
-0.27
-2.04%
TROV
10.93
+0.64
+6.22%
VICL
0.926
+0.036
+4.045%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
0.00
0.00%
ACAD
40.55
+0.33
+0.82%
AEMD
8.75
-0.1
-1.13%
APRI
1.56
+0.06
+4.00%
ARNA
4.19
-0.01
-0.24%
ATEC
1.36
+0.01
+0.74%
CNAT
5.36
+0.04
+0.75%
CRXM
0.5
0.00
0.00%
CYTX
0.66
-0.021
-3.0548%
DXCM
68.68
+0.43
+0.63%
GNMK
9.04
+0.01
+0.11%
HALO
17.45
+0.2
+1.16%
ILMN
205
+1.88
+0.93%
INNV
0.153
+0.003
+1.6667%
INO
8.83
+0.57
+6.90%
ISCO
0.05
0.00
0.00%
ISIS
67.76
+0.59
+0.88%
LGND
89.67
+0.44
+0.49%
LPTN
0.305
+0.008
+2.6599%
MBVX
2.29
-0.09
-3.78%
MEIP
1.87
-0.04
-2.09%
MNOV
4.05
+0.05
+1.25%
MRTX
26.81
+0.97
+3.75%
MSTX
0.49
-0.01
-2.97%
NBIX
42.55
+0.57
+1.36%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.65
-0.03
-0.64%
OREX
5.01
+0.01
+0.20%
OTIC
24.86
-6.19
-19.94%
QDEL
21.84
-0.89
-3.92%
RCPT
161.65
+1.54
+0.96%
RGLS
12.85
+0.1
+0.78%
RMD
57.08
-0.24
-0.42%
SCIE
0.02
+0.005
+30.2632%
SPHS
0.845
-0.014
-1.630%
SRNE
12.94
-0.27
-2.04%
TROV
10.93
+0.64
+6.22%
VICL
0.926
+0.036
+4.045%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
0.00
0.00%
Home » Archive by Category

Xconomy

WHO Approves 15-Minute Ebola Test Developed by Corgenix

February 20, 2015 – 11:38 am

Doctors who continue to battle the Ebola epidemic that rages on in Africa—even if it’s once again out of the headlines in the U.S.—might be getting a new tool thanks to Corgenix, a…

[[Click headline to continue reading.]]

Seragon CEO Rich Heyman Is Going on Hiatus

February 19, 2015 – 10:01 pm

The moving boxes are stacked in the hallways of San Diego’s Seragon Pharmaceuticals, and that means the end is near for CEO Rich Heyman. He’s fine with that. As Heyman put it, “I’m not going to go…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More

February 19, 2015 – 1:29 pm

We’ve grouped our items according to topic this week. First come the financings, led by the relocated Laguna Pharma in San Diego. Then comes the clinical and regulatory news, which is topped by…

[[Click headline to continue reading.]]

Fears Percolate as Billion-Dollar Private Company Valuations Climb

February 19, 2015 – 12:04 pm

There are 73 private companies in the world with valuations of more than $1 billion, up from 40 just one year ago, according to a report published by The Wall Street Journal yesterday. Some of those…

[[Click headline to continue reading.]]

For Life Science Industry, Social Media Takes on New Significance

February 19, 2015 – 4:00 am

It seemed like a question out of left field at the time: “How many of you maintain and monitor Twitter, Instagram, Facebook, and Tumblr accounts?” The question was posed by Jeremy Levin, former…

[[Click headline to continue reading.]]

Heat Biologics, OncoSec Collaborate on Cancer Immunotherapy

February 18, 2015 – 4:07 pm

Heat Biologics and OncoSec Medical are joining forces to see how their different approaches to cancer immunotherapy might work together. Durham, NC-based Heat (NASDAQ: HTBX) and San Diego-based…

[[Click headline to continue reading.]]

Biotech M&A by Slow Simmer: An Inside Look at the Build to Buy Deal

February 18, 2015 – 1:00 am

Here’s a question for consideration: What does it mean to acquire a virtual, single asset biotech that was ‘built’ for the sole purpose of being bought? The answer is much more complex than you might…

[[Click headline to continue reading.]]

Rechristened Laguna Pharmaceuticals Raises $30M, Moves To San Diego

February 17, 2015 – 5:30 am

Laguna Pharmaceuticals, founded in 2006 as a spinout of Cleveland, OH-based drug discovery and testing company ChanTest, has raised $30 million in a Series B round of venture funding and relocated in…

[[Click headline to continue reading.]]

Ready, Aim, CRISPR: Will Gene-Editing Tools Hit Their Targets?

February 17, 2015 – 4:30 am

Gene therapy is finally upon us. After more than two decades of work, one product is approved in Europe. Others are steadily advancing through clinical trials, and gene therapy companies are doing…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More

February 12, 2015 – 1:01 pm

Seattle might be second in professional handegg, but it comes first in this week’s West Coast roundup. The big news is that former high flyer Dendreon is all but sold, with the ever-acquisitive…

[[Click headline to continue reading.]]